Mark A Goldsmith Revolution Medicines, Inc. (RVMD) insider trading activity

Mark A Goldsmith is of Revolution Medicines, Inc.. Currently has a direct ownership of 232,469 shares of RVMD, which is worth approximately $15.7 Million. The most recent transaction as insider was on Dec 16, 2025, when has been sold 15,394 shares (Common Stock) at a price of $76.82 per share, resulting in proceeds of $1,182,567. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 232K

48.6% 3M change

34.68% 12M change

Total Value Held $15.7 Million

MARK A GOLDSMITH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 16 2025	SELL Open market or private sale	$1,182,567 $76.82 p/Share	15,394 Reduced 6.21%	232,469 Common Stock
Nov 25 2025	SELL Open market or private sale	$4,504,800 $75.08 p/Share	60,000 Reduced 19.49%	247,863 Common Stock
Nov 25 2025	BUY Exercise of conversion of derivative security	$245,400 $4.09 p/Share	60,000 Added 16.31%	307,863 Common Stock
Nov 18 2025	SELL Open market or private sale	$1,407,600 $70.38 p/Share	20,000 Reduced 7.47%	247,863 Common Stock
Nov 18 2025	BUY Exercise of conversion of derivative security	$81,800 $4.09 p/Share	20,000 Added 6.95%	267,863 Common Stock
Nov 12 2025	SELL Open market or private sale	$1,301,399 $65.07 p/Share	20,000 Reduced 7.47%	247,863 Common Stock
Nov 12 2025	SELL Bona fide gift	-	100,000 Reduced 28.75%	247,863 Common Stock

Nov 12 2025	BUY Exercise of conversion of derivative security	$81,800 $4.09 p/Share	20,000 Added 6.95%	267,863 Common Stock
Nov 07 2025	SELL Open market or private sale	$1,809,300 $60.31 p/Share	30,000 Reduced 7.94%	347,863 Common Stock
Nov 07 2025	BUY Exercise of conversion of derivative security	$78,300 $2.61 p/Share	30,000 Added 7.36%	377,863 Common Stock
Oct 17 2025	SELL Open market or private sale	$550,000 $55.0 p/Share	10,000 Reduced 2.16%	452,309 Common Stock
Oct 17 2025	BUY Exercise of conversion of derivative security	$11,200 $1.12 p/Share	10,000 Added 2.12%	462,309 Common Stock
Oct 16 2025	SELL Open market or private sale	$504,700 $50.47 p/Share	10,000 Reduced 2.16%	452,309 Common Stock
Oct 16 2025	BUY Exercise of conversion of derivative security	$11,200 $1.12 p/Share	10,000 Added 2.12%	462,309 Common Stock
Sep 16 2025	SELL Open market or private sale	$614,492 $45.82 p/Share	13,411 Reduced 2.88%	452,309 Common Stock
Jun 30 2025	BUY Exercise of conversion of derivative security	$19,980 $0.54 p/Share	37,000 Added 7.36%	465,720 Common Stock
Jun 16 2025	SELL Open market or private sale	$537,545 $39.83 p/Share	13,496 Reduced 3.05%	428,720 Common Stock
Mar 17 2025	SELL Open market or private sale	$458,251 $39.04 p/Share	11,738 Reduced 2.59%	441,564 Common Stock
Mar 01 2025	BUY Grant, award, or other acquisition	-	97,400 Added 17.69%	453,302 Common Stock
Dec 18 2024	BUY Exercise of conversion of derivative security	$15,114 $0.49 p/Share	30,846 Added 7.98%	355,902 Common Stock
Dec 16 2024	SELL Open market or private sale	$531,815 $45.4 p/Share	11,714 Reduced 3.48%	325,056 Common Stock
Nov 04 2024	SELL Open market or private sale	$2,828,004 $55.56 p/Share	50,900 Reduced 14.5%	300,170 Common Stock
Nov 04 2024	BUY Exercise of conversion of derivative security	$200,375 $2.29 p/Share	87,500 Added 20.62%	336,770 Common Stock
Nov 01 2024	SELL Open market or private sale	$500,682 $55.02 p/Share	9,100 Reduced 2.94%	300,170 Common Stock
Nov 01 2024	BUY Exercise of conversion of derivative security	$37,219 $4.09 p/Share	9,100 Added 2.86%	309,270 Common Stock

Also insider at

CNST

CONSTELLATION PHARMACEUTICALS INC Healthcare

MAG

Mark A Goldsmith

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVMD shares.

Notify only if

Value

Insider Trading

Get notified when an Revolution Medicines, Inc. insider buys or sells RVMD shares.

Notify only if

Operation

Value

Type

News

Receive news related to Revolution Medicines, Inc.

Track Activities on RVMD

Account